4//SEC Filing
AMICUS THERAPEUTICS INC 4
Accession 0001209191-15-074166
$FOLDCIK 0001178879operating
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 6:47 PM ET
Size
9.5 KB
Accession
0001209191-15-074166
Insider Transaction Report
Form 4
Peist Kenneth
VP, Intellectual Property
Transactions
- Sale
Common stock
2015-10-01$13.14/sh−10,000$131,362→ 3,187 total - Exercise/Conversion
Stock Options (right to buy)
2015-10-01−10,000→ 25,000 totalExercise: $6.45From: 2016-02-01Exp: 2022-02-15→ Common Stock (10,000 underlying) - Exercise/Conversion
Common stock
2015-10-01$13.14/sh+10,000$131,362→ 13,187 total
Footnotes (3)
- [F1]The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
- [F2]This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.58 to $13.75. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F3]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.58 to $13.75. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
AMICUS THERAPEUTICS INC
CIK 0001178879
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001178879
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 6:47 PM ET
- Size
- 9.5 KB